Duhaylungsod, Charlene T.
HRN: 20-15-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2022
CEFUROXIME 1.5GM (VIAL)
04/30/2022
04/30/2022
IVT
1.5g
Loading Dose
G1P0 39 2/7 Weeks AOG, Breech In Labor; For Stat 1° CS Due To Breech
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueIntra-abdominalReproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes